Synerkine Pharma
About:
Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.
Website: https://www.synerkinepharma.com/
Top Investors: InnovationQuarter, Thuja Capital, Netherlands Enterprise Agency, Flerie Invest, Utrecht Holdings
Description:
Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company's protein targets common regulatory mechanisms in different types of chronic pain and has unique properties, enabling patients to effectively reduce pain in multiple pre-clinical models.
12.1M EUR
$1M to $10M
Utrecht, Utrecht, The Netherlands
2009-01-01
Hans Preusting
1-10
2023-10-12
Private
© 2025 bioDAO.ai